Stock analysis searches answered, part 33 of 43

Nkarta

For “Nkarta”, the matching SEC registrant is Nkarta, Inc., which trades as NKTX and files under Central Index Key 1787400. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-10 (this view begins at filings dated on or before 2026-06-11), across 436 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-25 by Nkarta, Inc. (CIK 1787400) (passage 2, continuing from the earlier excerpt) — source document:

NKX019 is allogeneic, which means it is produced using cells from a different person than the patient(s) being treated, and it is produced in quantity, then frozen and therefore available for treating patients without delay, unlike autologous cell therapies, which are derived from a patient’s own cells and must be manufactured as needed for each patient. We believe that engineered NK cells have the potential to be effective and accessible therapies for autoimmune diseases and other diseases, be well tolerated, and avoid some of the toxicities observed with other cell therapies. NKX019 is currently being studied in an ongoing Phase 1 clinical trial ("Ntrust-1") for lupus nephritis ("LN") and primary membranous nephropathy ("pMN") and a Phase 1 clinical trial ("Ntrust-2") for systemic sclerosis ("scleroderma"), idiopathic inflammatory myopathy ("myositis"), and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis ("AAV").

Financial trend for Nkarta, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from -$21.71 million (2025-09-30) to -$40.37 million (2026-06-30), a change of -85.9%; total assets went from $427.24 million (2025-09-30) to $337.64 million (2026-06-30), a change of -21.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1787400, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Nkarta, Inc. did not tag for that period.

Nkarta, Inc. has 436 filings in its recent EDGAR index, including 6 annual reports and 19 quarterly reports; its newest filing is a 10-Q from 2026-08-10.

Current reports. Of the 60 8-K or 6-K reports in Nkarta, Inc.’s recent EDGAR index, the 4 listed here run from 2025-06-06 to 2026-03-25, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1787400 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2019-09-06. One example from this record is the 4 filed 2026-06-11 (document). Insider trades for Nkarta, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nklr

For “Nklr”, the matching SEC registrant is Terra Innovatum Global N.V., which trades as NKLR and files under Central Index Key 2067627. EDGAR puts it in the “Fabricated Plate Work (Boiler Shops)” industry code with Italy as its state or country of incorporation; its earlier registered name was Terra Innovatum Global S.R.L.. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEFA14A filed 2026-10-16, across 90 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-06-16 by Terra Innovatum Global N.V. (CIK 2067627) — source document:

Terra Innovatum Global N.V. ( “we,” “us,” “our,” “Terra,” “Terra Innovatum” or the “Company” ) was formed in connection with Terra Innovatum Global s.r.l.’s conversion into a Dutch public limited liability company ( naamloze vennootschap ), as contemplated by the Business Combination Agreement, and is headquartered in Lucca, Italy. Terra is a leading micro-modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with significant safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE).

Financial trend for Terra Innovatum Global N.V. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) went from -$34,000 (2024-12-31) to $539.52 million (2025-12-31), a change of +1586935.3%; total assets went from $134,000 (2024-12-31) to $106.14 million (2025-12-31), a change of +79106.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2067627, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Terra Innovatum Global N.V. did not tag for that period.

Terra Innovatum Global N.V. has 90 filings in its recent EDGAR index, including 1 annual reports and 3 quarterly reports; its newest filing is a DEFA14A from 2026-10-16.

Current reports. Of the 16 8-K or 6-K reports in Terra Innovatum Global N.V.’s recent EDGAR index, the 4 listed here run from 2026-08-27 to 2026-10-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2067627 is on the EDGAR company page; the latest 10-K there is dated 2026-06-16 and the oldest filing in the recent index dates from 2025-05-14. Insider trades for Terra Innovatum Global N.V. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

North america gas compression pricing market share archrock latest

For “North america gas compression pricing market share archrock latest”, the matching SEC registrant is Archrock, Inc., which trades as AROC and files under Central Index Key 1389050. EDGAR puts it in the “Natural Gas Transmission” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was EXTERRAN HOLDINGS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-28, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by Archrock, Inc. (CIK 1389050) — source document:

We are an energy infrastructure company with a primary focus on midstream natural gas compression and a commitment to helping our customers produce, compress and transport natural gas in a safe and environmentally responsible way. We are a premier provider of natural gas compression services, in terms of total compression fleet horsepower, to customers in the energy industry throughout the U.S., and a leading supplier of aftermarket services to customers that own compression equipment in the U.S. Our business supports a must–run service that is essential to the production, processing, transportation and storage of natural gas. We operate in two business segments: • Contract Operations – Our contract operations business primarily includes designing, sourcing, owning, installing, operating, servicing, repairing and maintaining our owned fleet of natural gas compression equipment to provide natural gas compression services to our customers. • Aftermarket Services – Our aftermarket services business provides a full range of services to support the compression needs of our customers that own compression equipment, including operations, maintenance, overhaul and reconfiguration services and sales of parts and components.

Financial trend for Archrock, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $845.57 million (2022-12-31) to $1.49 billion (2025-12-31), a change of +76.2%; net income (loss) went from $44.30 million (2022-12-31) to $322.29 million (2025-12-31), a change of +627.6%; total assets went from $2.60 billion (2022-12-31) to $4.35 billion (2025-12-31), a change of +67.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1389050, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Archrock, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Archrock, Inc. (CIK 1389050) filed 206 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-28, and its overall latest filing is a 8-K dated 2026-09-28. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 206 8-K or 6-K reports in Archrock, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-25 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1389050 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2012-08-13. Insider trades for Archrock, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Northwestern mutual annuities

What this search refers to. Northwestern Mutual is a mutual life insurer owned by its policyholders, so it has no shares and files no 10-K; its variable annuities are issued through separate accounts that do register with the SEC. Official source: www.sec.gov.

No SEC filer could be matched to “Northwestern mutual annuities” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Northwestern mutual annuities”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “northwestern” (search terms considered: northwestern, mutual, annuities).

EDGAR’s company index has 58 entities whose registered name contains the word “northwestern”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “northwestern” 58, “mutual” 422, “annuities” 46. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “northwestern”: AUSTIN & NORTHWESTERN RAILROAD CO INC (CIK 1123146), CAMPUS ACQUISITIONS 720 NORTHWESTERN, LLC (CIK 1567161), EVANSTON NORTHWESTERN HEALTHCARE FACULTY PRACTICE ASSOCIATES (CIK 1173311); containing “mutual”: 1-800 MUTUAL FUNDS INC (CIK 1073045), AAL MUTUAL FUNDS (CIK 811869), ABACUS MUTUAL FUNDS INC (CIK 1234315); containing “annuities”: BRIGHTHOUSE SEPARATE ACCOUNT ELEVEN FOR VARIABLE ANNUITIES (CIK 1209404), BRIGHTHOUSE SEPARATE ACCOUNT QPN FOR VARIABLE ANNUITIES (CIK 1298892), CG VARIABLE ANNUITY ACCOUNT I GROUP VARIABLE ANNUITIES FOR (CIK 310967). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “northwestern” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Northwestern mutual long-term care insurance

What this search refers to. Northwestern Mutual’s long-term care insurance is a state-regulated insurance product, so its filings are with state insurance departments; the company is mutual and policyholder-owned and does not issue stock. Official source: content.naic.org.

No SEC filer could be matched to “Northwestern mutual long-term care insurance” with a single, clear Central Index Key: the phrase “Northwestern mutual long-term care insurance” appears in 3 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “northwestern” (search terms considered: northwestern, mutual, long-term, care, insurance).

A broader EDGAR full-text search for the shorter phrase “Northwestern mutual long-term” finds 8 filing documents; among the top 8, the filers mentioning it most are LB SERIES FUND INC (CIK 0000790166) (3); Independence Contract Drilling, Inc. (ICD, ICDI) (CIK 0001537028) (1); NORTHWESTERN MUTUAL LIFE INSURANCE CO (CIK 0000073076) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 3 most relevant full-text hits returned for “Northwestern mutual long-term care insurance”, filings range from 2001-03-30 to 2014-07-18. The filers whose documents mention it most often are Independence Contract Drilling, Inc. (ICD, ICDI) (CIK 0001537028) (1 hit); NORTHWESTERN MUTUAL LIFE INSURANCE CO (CIK 0000073076) (1 hit); NML VARIABLE ANNUITY ACCOUNT A (CIK 0000790162) (1 hit); NML VARIABLE ANNUITY ACCT C OF NORTHWESTERN MUT LIFE INS CO (CIK 0000790163) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

Word by word, the number of EDGAR registrant names containing each term of this search is: “northwestern” 58, “mutual” 422, “long-term” 47, “care” 484, “insurance” 481. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Updated Oct 25, 2026 ET

Northwestern mutual ltc insurance

What this search refers to. “LTC” here means long-term care; Northwestern Mutual’s LTC coverage is regulated by state insurance departments, which the NAIC links to, rather than by the SEC. Official source: content.naic.org.

No SEC filer could be matched to “Northwestern mutual ltc insurance” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Northwestern mutual ltc insurance”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “northwestern” (search terms considered: northwestern, mutual, ltc, insurance).

Even the shorter phrase “Northwestern mutual ltc” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (northwestern, mutual, ltc, insurance) point to a business outside the SEC system or one known by another legal name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “northwestern” 58, “mutual” 422, “ltc” 28, “insurance” 481. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “northwestern”: NORTHWESTERN CAPITAL FINANCING II /DE/ (CIK 946938), NORTHWESTERN CAPITAL FINANCING III /DE/ (CIK 946940), NORTHWESTERN CORP (CIK 73088); containing “mutual”: ACTIVA MUTUAL FUND TRUST (CIK 6247), AF MUTUAL HOLDING CO (CIK 1250431), AGGRESSIVE GROWTH MUTUAL FUND PORTFOLIO (CIK 1107938); containing “ltc”: LTC FINANCIAL PARTNERS LLC (CIK 1231299), LTC - THE DON, LLC (CIK 1794764), LTC - THE FALCON, LLC (CIK 1903891); containing “insurance”: 26NORTH INSURANCE CO-INVESTMENT PARTNERS II LP (CIK 2021850), 26NORTH INSURANCE CO-INVESTMENT PARTNERS LP (CIK 1982114), 801 WEST INSURANCE FUND SERIES INTERESTS OF THE SALI MULTI-SERIES FUND, L.P. (CIK 2055917). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Updated Oct 25, 2026 ET

Nurix therapeutics

For “Nurix therapeutics”, the matching SEC registrant is Nurix Therapeutics, Inc., which trades as NRIX and files under Central Index Key 1549595. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Nurix, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-15, across 552 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-01-28 by Nurix Therapeutics, Inc. (CIK 1549595) — source document:

When used in this report, unless otherwise indicated, “Nurix,” “Company,” “we,” “us” and “our” refers to Nurix Therapeutics, Inc. and its wholly owned subsidiaries. Overview We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully artificial intelligence (AI)-integrated discovery engine capable of tackling any protein class, and coupled with leading ligase expertise, Nurix has built a significant advantage in translating the science of protein degradation into clinical advancements with the aim of establishing degrader-based treatments at the forefront of patient care.

Financial trend for Nurix Therapeutics, Inc. from annual reports, periods 2022-11-30 to 2025-11-30: revenue went from $38.63 million (2022-11-30) to $76.99 million (2023-11-30), a change of +99.3%; net income (loss) went from -$180.36 million (2022-11-30) to -$264.46 million (2025-11-30), a change of -46.6%; total assets went from $416.76 million (2022-11-30) to $688.13 million (2025-11-30), a change of +65.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1549595, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Nurix Therapeutics, Inc. did not tag for that period.

Nurix Therapeutics, Inc. has 552 filings in its recent EDGAR index, including 6 annual reports and 19 quarterly reports; its newest filing is a 4 from 2026-10-15.

Current reports. Of the 79 8-K or 6-K reports in Nurix Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-08 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1549595 is on the EDGAR company page; the latest 10-K there is dated 2026-01-28 and the oldest filing in the recent index dates from 2012-05-15. Insider trades for Nurix Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nus iris reddit

What this search refers to. “NUS iris reddit” asks for forum discussion about an “Iris” item at NUS (the National University of Singapore); no company of that name files with the SEC, and forum threads are not an official source. Corporate-registry check: OpenCorporates search for “Nus iris reddit”.

No SEC filer could be matched to “Nus iris reddit” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Nus iris”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “nus” (search terms considered: nus, iris).

EDGAR’s company index has 27 entities whose registered name contains the word “nus”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “nus” 27, “iris” 103. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “nus”: BROOKFIELD CAPITAL PARTNERS VII-NUS L.P. (CIK 2101765), BROOKFIELD PREMIER REAL ESTATE PARTNERS (NUS TE) L.P. (CIK 1994450), BROOKFIELD PREMIER REAL ESTATE PARTNERS (NUS) L.P. (CIK 1758262); containing “iris”: ALVARADO IRIS (CIK 1541739), ANIMA IRIS JUN 2025 A SERIES OF CGF2021 LLC (CIK 2092477), ARCO-IRIS GOLD CORP (CIK 1577423). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: forum posts about “nus” are not disclosures, and Investor.gov flags social-media hype about thinly traded tickers as a classic pump-and-dump warning sign. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Nvni stock

For “Nvni stock”, the matching SEC registrant is Nvni Group Ltd, which trades as NVNIF, NVNWF and files under Central Index Key 1965143. EDGAR puts it in the “Services-Prepackaged Software” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-09, across 136 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by Nvni Group Ltd (CIK 1965143) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 71 A. Operating Results 71 B. Liquidity and Capital Resources 87 C. Research and Development, Patents and Licenses, etc. 97 D. Trend Information 97 E. Critical Accounting Estimates 97 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 98 A. Directors and Senior Management 98 B. Compensation 100 C. Board Practices 101 D. Employees 106 E. Share Ownership 107 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 107 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 108 A. Major Shareholders 108 B. Related Party Transactions 109 C. Interests of Experts and Counsel 113 ITEM 8. FINANCIAL INFORMATION 113 A. Consolidated Statements and Other Financial Information 113 B. Significant Changes 114 ITEM 9.

Financial trend for Nvni Group Ltd from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 89,864,000 BRL (2021-12-31) to 193,282,000 BRL (2024-12-31), a change of +115.1%; net income (loss) went from -77,699,000 BRL (2021-12-31) to -78,209,000 BRL (2024-12-31), a change of -0.7%; total assets went from 367,065,000 BRL (2022-12-31) to 405,393,000 BRL (2024-12-31), a change of +10.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1965143, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Nvni Group Ltd did not tag for that period.

Nvni Group Ltd has 136 filings in its recent EDGAR index, including 4 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-09.

Current reports. Of the 67 8-K or 6-K reports in Nvni Group Ltd’s recent EDGAR index, the 4 listed here run from 2026-08-03 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1965143 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2023-02-27. Insider trades for Nvni Group Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nyxoah

For “Nyxoah”, the matching SEC registrant is Nyxoah SA, which trades as NYXH and files under Central Index Key 1857190. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with Belgium as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20 (this view begins at filings dated on or before 2026-06-11), across 178 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-26 by Nyxoah SA (CIK 1857190) (passage 2, continuing from the earlier excerpt) — source document:

Our headquarters and principal executive offices are located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium, and our telephone number is +32 10 45 90 75. Our website address is www.nyxoah.com. Our website and the information contained on or accessible through our website are not part of this Annual Report. Our authorized representative in the United States is Nyxoah, Inc. Our agent for service of process in the United States is Corporation Service Company, 1090 Vermont Avenue N.W., Washington D.C. 20005. We file reports and other information with the SEC. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC (http://www.sec.gov).

Financial trend for Nyxoah SA from quarterly and annual reports (three-month periods), periods 2024-06-30 to 2025-06-30: net income (loss) went from -13,124,000 EUR (2024-06-30) to -20,607,000 EUR (2025-06-30), a change of -57.0%; total assets went from 148,232,000 EUR (2024-06-30) to 116,470,000 EUR (2025-06-30), a change of -21.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1857190, tags Assets, ProfitLoss; 2 periods shown, dashes mark figures Nyxoah SA did not tag for that period.

Nyxoah SA has 178 filings in its recent EDGAR index, including 5 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-20.

Current reports. Of the 110 8-K or 6-K reports in Nyxoah SA’s recent EDGAR index, the 4 listed here run from 2026-06-08 to 2026-07-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1857190 is on the EDGAR company page; the latest 20-F there is dated 2026-03-26 and the oldest filing in the recent index dates from 2021-04-16. One example from this record is the 6-K filed 2026-08-05 (document). Insider trades for Nyxoah SA appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Oportun inc. mobile apps

For “Oportun inc. mobile apps”, the matching SEC registrant is Oportun, Inc., which trades as none listed and files under Central Index Key 1478295. EDGAR puts it in the “no SIC description” industry code with DE as its state or country of incorporation; its earlier registered name was Progress Financial Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a ABS-15G filed 2025-02-10, across 30 filings on record. This is reference material, not trading advice.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Oportun, Inc. (CIK 1478295) lists its business address as 1600 SEAPORT BLVD., SUITE 250, REDWOOD CITY, CA, which helps confirm you are on the right company’s site.

What kind of filer this is matters for “Oportun inc. mobile apps”: Oportun, Inc.’s EDGAR record from 2009-12-09 to 2025-02-10 consists only of ABS-15G filings; D/A filings; Form D notices of exempt private offerings, which means it raised money privately rather than registering shares for public trading. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 30 recent EDGAR filings, Oportun, Inc. most often filed ABS-15G (25), D (4), D/A (1). A selection from 2021-02-18 to 2025-02-10:

The full record for CIK 1478295 is on the EDGAR company page and the oldest filing in the recent index dates from 2009-12-09. Insider trades for Oportun, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Oric-101 sec filing

For “Oric-101 sec filing”, the matching SEC registrant is Oric Pharmaceuticals, Inc., which trades as ORIC and files under Central Index Key 1796280. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-23, across 423 filings on record. This is reference material, not trading advice.

Financial trend for Oric Pharmaceuticals, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$89.12 million (2022-12-31) to -$129.47 million (2025-12-31), a change of -45.3%; total assets went from $247.18 million (2022-12-31) to $408.89 million (2025-12-31), a change of +65.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1796280, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Oric Pharmaceuticals, Inc. did not tag for that period.

Oric Pharmaceuticals, Inc. has 423 filings in its recent EDGAR index, including 6 annual reports and 20 quarterly reports; its newest filing is a 8-K from 2026-10-23.

Current reports. Of the 65 8-K or 6-K reports in Oric Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 423 recent EDGAR filings, Oric Pharmaceuticals, Inc. most often filed 4 (148), 8-K (65), SC 13G/A (23), 144 (21). A selection from 2026-09-29 to 2026-10-21:

The full record for CIK 1796280 is on the EDGAR company page; the latest 10-K there is dated 2026-02-23 and the oldest filing in the recent index dates from 2019-12-13. Insider trades for Oric Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Os therapies pasithea inmode sab biotherapeutics latest news

Four small-cap health companies searched together for latest news. What follows is each company’s own disclosure trail as EDGAR showed it on Oct 25, 2026.

SAB Biotherapeutics, Inc. (SABS; biological products, (no diagnostic substances), incorporated in DE): its index shows the 8-K of 2026-10-13 covering 8.01 (other events), 9.01 (financial statements and exhibits); the 8-K of 2026-07-07 covering 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits). Year to 2025-12-31: reported revenue $0, bottom line $13.27 million (10-K, 2026-03-09).

OS Therapies Inc (OSTX; pharmaceutical preparations, incorporated in DE) — EDGAR lists the 8-K of 2026-10-19 covering 1.01 (entry into a material definitive agreement), 3.02 (unregistered sales of equity securities), 8.01 (other events), 9.01 (financial statements and exhibits); the 8-K of 2026-10-05 covering 1.01 (entry into a material definitive agreement), 5.02 (departure/election of directors or officers), 8.01 (other events), 9.01 (financial statements and exhibits). Its latest annual report is the 10-K filed 2026-03-31.

Pasithea Therapeutics Corp. (KTTA; pharmaceutical preparations, incorporated in DE): its index shows the 8-K of 2026-09-16 covering 8.01 (other events); the 8-K of 2026-09-09 covering 5.07 (submission of matters to a vote of security holders), 9.01 (financial statements and exhibits). Year to 2022-12-31: reported revenue $486,559, bottom line -$13.94 million (10-K, 2023-03-30).

InMode Ltd. (INMD; electromedical & electrotherapeutic apparatus, incorporated in Israel) — recent current reports: the 6-K of 2026-09-16; the 6-K of 2026-08-11. Year to 2025-12-31: revenue of $370.50 million (20-F, 2026-02-10).

Item 2.02 — results of operations and financial condition — the item that accompanies an earnings release — appears this many times per company: SABS 3 (latest 2024-03-29), OSTX 5 (latest 2025-08-19), KTTA 0, INMD 0.

Updated Oct 25, 2026 ET

Perella weinberg

For “Perella weinberg”, the matching SEC registrant is Perella Weinberg Partners, which trades as PWP and files under Central Index Key 1777835. EDGAR puts it in the “Finance Services” industry code with DE as its state or country of incorporation; its earlier registered name was FinTech Acquisition Corp. IV. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-20, across 546 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by Perella Weinberg Partners (CIK 1777835) — source document:

We are a leading global independent advisory firm that provides strategic and financial advice to clients across the most active industry sectors and international markets. Our wide range of global clients include large public multinational corporations, mid-sized public and private companies, financial sponsors, individual entrepreneurs, private and institutional investors, creditor committees and government institutions. We were founded in June 2006 with the opening of offices in New York and London, led by a team of ten seasoned advisory partners who previously held senior management positions at large global investment banks. The foundation of our Company was rooted in a belief, among other considerations, that clients would increasingly seek out deeply experienced advisors who offer independent strategic thinking and who are not burdened by the complicated conflicts that large investment banking institutions may face due to their various businesses.

Financial trend for Perella Weinberg Partners from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $631.51 million (2022-12-31) to $750.90 million (2025-12-31), a change of +18.9%; net income (loss) went from $17.88 million (2022-12-31) to $35.48 million (2025-12-31), a change of +98.4%; total assets went from $717.09 million (2022-12-31) to $797.64 million (2025-12-31), a change of +11.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1777835, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Perella Weinberg Partners did not tag for that period.

Perella Weinberg Partners has 546 filings in its recent EDGAR index, including 6 annual reports and 18 quarterly reports; its newest filing is a 4 from 2026-10-20.

Current reports. Of the 67 8-K or 6-K reports in Perella Weinberg Partners’s recent EDGAR index, the 4 listed here run from 2026-05-29 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1777835 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2019-06-14. Insider trades for Perella Weinberg Partners appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Performance food group pfgc latest news october 2026

For “Performance food group pfgc latest news october 2026”, the matching SEC registrant is Performance Food Group Co, which trades as PFGC and files under Central Index Key 1618673. EDGAR puts it in the “Wholesale-Groceries, General Line” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a ARS filed 2026-10-09, across 1001 filings on record. This is reference material, not trading advice.

Financial trend for Performance Food Group Co from annual reports, periods 2023-07-01 to 2026-06-27: net income (loss) went from $397.20 million (2023-07-01) to $359.30 million (2026-06-27), a change of -9.5%; total assets went from $12.50 billion (2023-07-01) to $18.85 billion (2026-06-27), a change of +50.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1618673, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Performance Food Group Co did not tag for that period.

For the latest news, the fastest official source is the filing feed: Performance Food Group Co (CIK 1618673) filed 135 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-24, and its overall latest filing is a ARS dated 2026-10-09. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 135 8-K or 6-K reports in Performance Food Group Co’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-08-24, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1001 recent EDGAR filings, Performance Food Group Co most often filed 4 (594), 8-K (135), 144 (75), SC 13G/A (41). A selection from 2026-09-29 to 2026-10-09:

The full record for CIK 1618673 is on the EDGAR company page; the latest 10-K there is dated 2026-08-12 and the oldest filing in the recent index dates from 2016-11-23. Insider trades for Performance Food Group Co appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Plains all american south bow williams kinder morgan midstream deal

Midstream pipeline companies searched for a deal; South Bow is the Canadian spin-off of TC Energy’s liquids pipelines. Every name is matched to its own EDGAR record (checked Oct 25, 2026), since none of these companies reports on behalf of another.

PLAINS ALL AMERICAN PIPELINE LP (PAA; pipe lines (no natural gas), incorporated in DE) — EDGAR lists the 8-K of 2026-09-29 covering 5.02 (departure/election of directors or officers), 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits); the 8-K of 2026-09-14 covering 1.01 (entry into a material definitive agreement), 2.03 (creation of a direct financial obligation), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2025-12-31: annual sales of $44.26 billion, net result $1.44 billion (10-K, 2026-02-27).

KINDER MORGAN, INC. (KMI; natural gas transmission, incorporated in DE) — EDGAR lists the 8-K of 2026-10-21 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-09-28 covering 7.01 (regulation fd disclosure). Year to 2025-12-31: annual sales of $16.94 billion, net result $3.06 billion (10-K, 2026-02-13).

South Bow Corp (SOBO; pipe lines (no natural gas), incorporated in Canada (Federal Level)) filed the 6-K of 2026-10-07; the 6-K of 2026-08-05. Year to 2025-12-31: FY revenue tagged at $1.99 billion, profit or loss $433.00 million (40-F, 2026-03-16).

WILLIAMS COMPANIES, INC. (WMB; natural gas transmission, incorporated in DE) — EDGAR lists the 8-K of 2026-09-10 covering 1.01 (entry into a material definitive agreement), 9.01 (financial statements and exhibits); the 8-K of 2026-09-10 covering 7.01 (regulation fd disclosure), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2025-12-31: annual sales of $11.95 billion, net result $2.62 billion (10-K, 2026-02-24).

Frequency of Item 2.01 (completion of an acquisition or disposition of assets) in recent filings — PAA 8 (latest 2026-08-07), KMI 1 (latest 2014-12-03), SOBO 0, WMB 2 (latest 2018-08-10).

Updated Oct 25, 2026 ET

Planet holdco 2 ltd kkr us

“Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. The name “Planet holdco 2 ltd kkr us” therefore points to a company organised in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), and its official disclosures are on that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk), not on EDGAR.

No SEC filer could be matched to “Planet holdco 2 ltd kkr us” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Planet holdco 2 ltd kkr us”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “planet” (search terms considered: planet, holdco, kkr).

Even the shorter phrase “Planet holdco 2” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (planet, holdco, kkr) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 141 entities whose registered name contains the word “planet”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “planet” 141, “holdco” 493, “kkr” 480. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “planet”: 5TH PLANET GAMES INC. (CIK 1613746), ABLE PLANET INC (CIK 1344214), AIP-SHACK/PLANET LLC (CIK 1454693); containing “holdco”: 100 EAST HOLDCO, LLC (CIK 1993765), 11321 WOODMEADOW HOLDCO, LLC (CIK 2064284), 13822 SOUTH 46TH PLACE HOLDCO, LLC (CIK 1764035); containing “kkr”: 2015 SELECT OPPORTUNITIES KKR ACCESS FUND, LLC (CIK 1661329), ACCEL KKR CAPITAL PARTNERS III LP (CIK 1438993), ACCEL-KKR CAPITAL PARTNERS CV III, LP (CIK 1781975). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “planet” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pluri-biotech.com plx-pad

For “Pluri-biotech.com plx-pad”, the matching SEC registrant is Pluri Inc., which trades as PLUR and files under Central Index Key 1158780. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with NV as its state or country of incorporation; its earlier registered name was PLURISTEM THERAPEUTICS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 950 filings on record. This is reference material, not trading advice.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Pluri Inc. (CIK 1158780) lists its business address as MATAM ADVANCED TECHNOLOGY PARK, HAIFA, which helps confirm you are on the right company’s site.

Updated Oct 25, 2026 ET

Pluri-biotech.com plx-pad news

For “Pluri-biotech.com plx-pad news”, the matching SEC registrant is Pluri Inc., which trades as PLUR and files under Central Index Key 1158780. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with NV as its state or country of incorporation; its earlier registered name was PLURISTEM THERAPEUTICS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20 (this view begins at filings dated on or before 2026-08-27), across 950 filings on record. This is reference material, not trading advice.

Financial trend for Pluri Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-03-31: revenue went from $316,000 (2025-09-30) to $167,000 (2026-03-31), a change of -47.2%; net income (loss) went from -$5.85 million (2025-09-30) to -$5.55 million (2026-03-31), a change of +5.2%; total assets went from $33.67 million (2025-09-30) to $26.06 million (2026-03-31), a change of -22.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1158780, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Pluri Inc. did not tag for that period.

Current reports. Of the 248 8-K or 6-K reports in Pluri Inc.’s recent EDGAR index, the 4 listed here run from 2026-03-27 to 2026-07-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1158780 is on the EDGAR company page; the latest 10-K there is dated 2026-09-10 and the oldest filing in the recent index dates from 2001-09-10. One example from this record is the S-8 filed 2026-09-11 (document). Insider trades for Pluri Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Poet technologies latest news bull bear case

For “Poet technologies latest news bull bear case”, the matching SEC registrant is POET TECHNOLOGIES INC., which trades as POET and files under Central Index Key 1437424. EDGAR puts it in the “Semiconductors & Related Devices” industry code with Ontario, Canada as its state or country of incorporation; its earlier registered name was OPEL INTERNATIONAL INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-19, across 487 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-31 by POET TECHNOLOGIES INC. (CIK 1437424) — source document:

The legal and commercial name of the Company is POET Technologies Inc. The Company was originally incorporated under the British Columbia Company Act on February 9, 1972 as Tandem Resources Ltd. On November 14, 1985, Tandem Resources Ltd. amalgamated with Stanmar Resources Ltd. and Keezic Resources Ltd., to continue as one company under the name Tandem Resources Ltd. under the British Columbia Company Act. By Articles of Continuance dated January 3, 1997, Tandem Resources Ltd. was continued under the OBCA. By Articles of Amendment dated September 26, 2006, Tandem Resources Ltd. changed its name to OPEL International Inc. By Certificate of Continuance dated January 30, 2007, OPEL International Inc. was continued under the New Brunswick Business Corporations Act.

Financial trend for POET TECHNOLOGIES INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $552,748 (2022-12-31) to $1.07 million (2025-12-31), a change of +94.5%; net income (loss) went from -$21.04 million (2022-12-31) to -$62.96 million (2025-12-31), a change of -199.3%; total assets went from $15.39 million (2022-12-31) to $328.57 million (2025-12-31), a change of +2034.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1437424, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures POET TECHNOLOGIES INC. did not tag for that period.

For the latest news, the fastest official source is the filing feed: POET TECHNOLOGIES INC. (CIK 1437424) filed 385 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-19, and its overall latest filing is a 6-K dated 2026-10-19. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 385 8-K or 6-K reports in POET TECHNOLOGIES INC.’s recent EDGAR index, the 4 listed here run from 2026-08-13 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1437424 is on the EDGAR company page; the latest 20-F there is dated 2026-03-31 and the oldest filing in the recent index dates from 2008-04-23. Insider trades for POET TECHNOLOGIES INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Prestige consumer healthcare pbh latest news

For “Prestige consumer healthcare pbh latest news”, the matching SEC registrant is Prestige Consumer Healthcare Inc., which trades as PBH and files under Central Index Key 1295947. EDGAR puts it in the “Pharmaceutical Preparations” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was Prestige Brands Holdings, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-14, across 1000 filings on record. This is reference material, not trading advice.

We develop our existing brands by investing in new product lines, brand extensions and strong advertising support. Acquisitions of consumer health and personal care brands have also been an important part of our growth strategy. We pursue this growth following an acquisition through spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations and innovative development of brand extensions. We conduct our operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare.

Updated Oct 25, 2026 ET

Prov provident financial holdings sec filing news

For “Prov provident financial holdings sec filing news”, the matching SEC registrant is PROVIDENT FINANCIAL HOLDINGS INC, which trades as PROV and files under Central Index Key 1010470. EDGAR puts it in the “Savings Institution, Federally Chartered” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-23, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-09-02 by PROVIDENT FINANCIAL HOLDINGS INC (CIK 1010470) — source document:

Provident Financial Holdings, Inc. (the “Corporation”), a Delaware corporation, was organized in January 1996 for the purpose of becoming the holding company of Provident Savings Bank, F.S.B. (the “Bank”) upon the Bank’s conversion from a federal mutual to a federal stock savings bank (“Conversion”). The Conversion was completed in June 1996. The Corporation is regulated by the Board of Governors of the Federal Reserve System (“Federal Reserve”). At June 30, 2026, the Corporation had consolidated total assets of $1.21 billion, total deposits of $910.4 million and stockholders’ equity of $126.2 million. The Corporation has not engaged in any significant activity other than holding the stock of the Bank. As used in this report, the terms “we,” “our,” “us,” and the “Corporation” refer to Provident Financial Holdings, Inc. and its consolidated subsidiaries, unless the context indicates otherwise.

Financial trend for PROVIDENT FINANCIAL HOLDINGS INC from annual reports, periods 2023-06-30 to 2026-06-30: revenue went from $45.99 million (2023-06-30) to $55.89 million (2026-06-30), a change of +21.5%; net income (loss) went from $8.59 million (2023-06-30) to $6.66 million (2026-06-30), a change of -22.5%; total assets went from $1.33 billion (2023-06-30) to $1.21 billion (2026-06-30), a change of -9.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1010470, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures PROVIDENT FINANCIAL HOLDINGS INC did not tag for that period.

For reported results, PROVIDENT FINANCIAL HOLDINGS INC’s (CIK 1010470) latest 10-Q is dated 2026-05-07 and its latest annual report (10-K) 2026-09-02. Earnings releases appear as 8-K Item 2.02 filings; 90 are in the recent index, the newest on 2026-07-28.

For the latest news, the fastest official source is the filing feed: PROVIDENT FINANCIAL HOLDINGS INC (CIK 1010470) filed 359 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-23, and its overall latest filing is a 8-K dated 2026-10-23. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 359 8-K or 6-K reports in PROVIDENT FINANCIAL HOLDINGS INC’s recent EDGAR index, the 4 listed here run from 2026-07-24 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1010470 is on the EDGAR company page; the latest 10-K there is dated 2026-09-02 and the oldest filing in the recent index dates from 2003-05-14. Insider trades for PROVIDENT FINANCIAL HOLDINGS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pt bank smbc indonesia tbk

EDGAR offers no single, clearly identifiable registrant for “Pt bank smbc indonesia tbk” that this page could attach a CIK to — the phrase “Pt bank smbc indonesia tbk” appears in 12 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “smbc” (search terms considered: bank, smbc, indonesia).

Looking at the 12 top-ranked full-text results for “Pt bank smbc indonesia tbk”, filings range from 2025-05-30 to 2026-06-26. The filers whose documents mention it most often are SUMITOMO MITSUI FINANCIAL GROUP, INC. (SMFG, SMFNF) (CIK 0001022837) (11 hits); PT Sarana Menara Nusantara Tbk (CIK 0002048388) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

One more angle on this search: when “smbc” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pwp wso

What this search refers to. “PWP WSO” pairs PWP, the Nasdaq ticker of Perella Weinberg Partners, with “WSO”, the NYSE ticker of Watsco; the two are unrelated SEC filers, so this page does not attach either company’s data to the combined query. Official source: www.sec.gov.

No SEC filer could be matched to “Pwp wso” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Pwp wso”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “pwp” (search terms considered: pwp, wso).

EDGAR’s company index has 30 entities whose registered name contains the word “pwp”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “pwp” 30, “wso” 1. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “pwp”: PWP ALPHA EUROPE FUND LP (CIK 1548854), PWP ALPHA EUROPE LONG ONLY OFFSHORE FUND LTD. (CIK 1438743), PWP ASSET BASED INCOME ASP FUND, A SERIES OF ALTERNATIVE STRATEGIES PLATFORM, LLC (CIK 1569730); containing “wso”: WSO HOLDINGS, LP (CIK 1545328). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “pwp” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Quantumscape lounge

For “Quantumscape lounge”, the matching SEC registrant is QuantumScape Corp, which trades as QS and files under Central Index Key 1811414. EDGAR puts it in the “Miscellaneous Electrical Machinery, Equipment & Supplies” industry code with DE as its state or country of incorporation; its earlier registered name was Kensington Capital Acquisition Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-10-23, across 994 filings on record. This is reference material, not trading advice.

Financial trend for QuantumScape Corp from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$411.91 million (2022-12-31) to -$435.05 million (2025-12-31), a change of -5.6%; total assets went from $1.48 billion (2022-12-31) to $1.31 billion (2025-12-31), a change of -11.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1811414, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures QuantumScape Corp did not tag for that period.

QuantumScape Corp has 994 filings in its recent EDGAR index, including 6 annual reports and 20 quarterly reports; its newest filing is a 10-Q from 2026-10-23.

Current reports. Of the 93 8-K or 6-K reports in QuantumScape Corp’s recent EDGAR index, the 4 listed here run from 2026-06-05 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 994 recent EDGAR filings, QuantumScape Corp most often filed 4 (463), 144 (197), 8-K (93), 424B3 (40). A selection from 2026-08-25 to 2026-10-23:

The full record for CIK 1811414 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2020-05-08. Insider trades for QuantumScape Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quest diagnostics breach

For “Quest diagnostics breach”, the matching SEC registrant is QUEST DIAGNOSTICS INC, which trades as DGX and files under Central Index Key 1022079. EDGAR puts it in the “Services-Medical Laboratories” industry code with DE as its state or country of incorporation; its earlier registered name was CORNING CLINICAL LABORATORIES INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-23, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by QUEST DIAGNOSTICS INC (CIK 1022079) — source document:

Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. In the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. The patients we serve annually comprise approximately one-third of the adult population of the United States, and over a three-year period, we serve approximately one-half of the adult population of the United States.

Financial trend for QUEST DIAGNOSTICS INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $9.88 billion (2022-12-31) to $11.04 billion (2025-12-31), a change of +11.7%; net income (loss) went from $946.00 million (2022-12-31) to $992.00 million (2025-12-31), a change of +4.9%; total assets went from $12.84 billion (2022-12-31) to $16.23 billion (2025-12-31), a change of +26.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1022079, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures QUEST DIAGNOSTICS INC did not tag for that period.

QUEST DIAGNOSTICS INC has 1000 filings in its recent EDGAR index, including 10 annual reports and 31 quarterly reports; its newest filing is a 4 from 2026-10-23.

Current reports. Of the 117 8-K or 6-K reports in QUEST DIAGNOSTICS INC’s recent EDGAR index, the 4 listed here run from 2026-07-23 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1022079 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2016-08-04. Insider trades for QUEST DIAGNOSTICS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rani therapeutics

For “Rani therapeutics”, the matching SEC registrant is Rani Therapeutics Holdings, Inc., which trades as RANI and files under Central Index Key 1856725. EDGAR puts it in the “Pharmaceutical Preparations” industry code with CA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-29, across 380 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-26 by Rani Therapeutics Holdings, Inc. (CIK 1856725) — source document:

We are a clinical stage biotherapeutics company focusing on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. We are advancing a portfolio of oral therapeutics using our proprietary delivery technology and we are actively pursuing partnering the technology with third party biopharmaceutical companies for the oral delivery of their biologics and drugs. Our technology comprises a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. We have two configurations of the platform – the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability.

Financial trend for Rani Therapeutics Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2022-12-31) to $1.63 million (2025-12-31); net income (loss) went from -$30.59 million (2022-12-31) to -$29.67 million (2025-12-31), a change of +3.0%; total assets went from $108.03 million (2022-12-31) to $58.62 million (2025-12-31), a change of -45.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1856725, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Rani Therapeutics Holdings, Inc. did not tag for that period.

Rani Therapeutics Holdings, Inc. has 380 filings in its recent EDGAR index, including 5 annual reports and 16 quarterly reports; its newest filing is a 4 from 2026-09-29.

Current reports. Of the 63 8-K or 6-K reports in Rani Therapeutics Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-29 to 2026-08-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1856725 is on the EDGAR company page; the latest 10-K there is dated 2026-03-26 and the oldest filing in the recent index dates from 2021-04-27. Insider trades for Rani Therapeutics Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rdhl

For “Rdhl”, the matching SEC registrant is RedHill Biopharma Ltd., which trades as RDHL and files under Central Index Key 1553846. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Israel as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-21, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-27 by RedHill Biopharma Ltd. (CIK 1553846) — source document:

Our legal and commercial name is RedHill Biopharma Ltd. Our company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. Our principal executive offices are located at 21 Ha’arba’a Street, Tel-Aviv, Israel, and our telephone number is +972-3-5413131. In February 2011, we completed our initial public offering in Israel, pursuant to which we issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, we completed the listing of ADSs on Nasdaq, and on July 20, 2018, the ADSs were listed on the Nasdaq Global Market.

Financial trend for RedHill Biopharma Ltd. from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from $85.76 million (2021-12-31) to $8.04 million (2024-12-31), a change of -90.6%; net income (loss) went from -$97.74 million (2021-12-31) to -$8.27 million (2024-12-31), a change of +91.5%; total assets went from $181.19 million (2021-12-31) to $18.04 million (2024-12-31), a change of -90.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1553846, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures RedHill Biopharma Ltd. did not tag for that period.

RedHill Biopharma Ltd. has 1000 filings in its recent EDGAR index, including 13 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-21.

Current reports. Of the 758 8-K or 6-K reports in RedHill Biopharma Ltd.’s recent EDGAR index, the 4 listed here run from 2026-10-07 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1553846 is on the EDGAR company page; the latest 20-F there is dated 2026-04-27 and the oldest filing in the recent index dates from 2013-03-04. Insider trades for RedHill Biopharma Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rekor systems sec filing october 2026

For “Rekor systems sec filing october 2026”, the matching SEC registrant is Rekor Systems, Inc., which trades as REKR and files under Central Index Key 1697851. EDGAR puts it in the “Communications Equipment, NEC” industry code with DE as its state or country of incorporation; its earlier registered name was Novume Solutions, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-19 (this view begins at filings dated on or before 2026-05-01), across 574 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Rekor Systems, Inc. (CIK 1697851) (passage 3, continuing from the earlier excerpt) — source document:

Although this technology was developed to respond to requests from public safety customers, we believe it has broad applicability and should therefore be pursued as a separate venture. A New Operating System for Roadways We believe the United States of America stands at a critical turning point in the evolution of its transportation and roadway infrastructure. For over 70 years, the nation has relied on analog technologies and manual methodologies that have resulted in inefficiencies, rising costs, and preventable safety hazards. While private-sector innovations like sensor technology, Internet of Things (“IoT”), AI, cloud computing, autonomous vehicles, and smart drones are advancing rapidly, fundamental challenges such as poor roadway quality, traffic congestion, and driver safety continue to present a challenge.

Financial trend for Rekor Systems, Inc. from annual reports, periods 2018-12-31 to 2021-12-31: revenue went from $20.05 million (2018-12-31) to $9.23 million (2020-12-31), a change of -54.0%; net income (loss) went from -$5.70 million (2018-12-31) to -$26.78 million (2021-12-31), a change of -369.6%; total assets went from $18.05 million (2018-12-31) to $125.88 million (2021-12-31), a change of +597.2%. Values are as filed and not adjusted for restatements, splits or currency.

Rekor Systems, Inc. has 574 filings in its recent EDGAR index, including 9 annual reports and 28 quarterly reports; its newest filing is a 8-K from 2026-10-19.

Current reports. Of the 165 8-K or 6-K reports in Rekor Systems, Inc.’s recent EDGAR index, the 4 listed here run from 2026-01-16 to 2026-05-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1697851 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2017-02-10. One example from this record is the 10-Q filed 2026-08-13 (document). Insider trades for Rekor Systems, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rto policy updates silicon valley

Also searched as: rto policy updates silicon valley -site:youtube.com -site:reddit.com -site:x.com -site:twitter.com -site:facebook.com -site:instagram.com -site:tiktok.com -site:linkedin.com -site:pinterest.com -site:nytimes.com -site:wsj.com -site:yelp.com -site:rottentomatoes.com

What this search refers to. “RTO policy updates Silicon Valley” is about return-to-office policies at technology employers; companies are not required to file such policies with the SEC, so updates come from company announcements and news reporting. Corporate-registry check: OpenCorporates search for “Rto policy updates silicon valley”.

No SEC filer could be matched to “Rto policy updates silicon valley” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Rto policy updates silicon valley”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “rto” (search terms considered: rto, policy, updates, silicon, valley).

Even the shorter phrase “Rto policy updates” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (rto, policy, updates, silicon, valley) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 10 entities whose registered name contains the word “rto”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “rto” 10, “policy” 18, “updates” 2, “silicon” 205, “valley” 482. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “rto”: RTO BENEFITS, LLC (CIK 1623564), RTO ENERGY TRADING HOLDINGS, LLC (CIK 1629589), RTO ENERGY TRADING. LLC (CIK 1612636); containing “policy”: AIR POLICY PORTFOLIO I, LP (CIK 1815894), AIR POLICY PORTFOLIO II, LP (CIK 1856315), COMPETITION POLICY ASSOCIATES, INC. (CIK 1353710); containing “updates”: CHURCH UPDATES, LLC (CIK 1610712), MEDICAL UPDATES INC (CIK 1183379); containing “silicon”: 6N SILICON INC (CIK 1432934), AC-0504 FUND I, A SERIES OF SILICON VALLEY CISO, LP (CIK 2134931), ADVANCED SILICON GROUP, INC. (CIK 1861637); containing “valley”: 1 VALLEY VIEW GROUP, LLC (CIK 1634723), 15300 VALLEY VIEW AVE WAREHOUSING LLC (CIK 1761677), 1655 VALLEY APF LP (CIK 1514009). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: for recent news on “rto”, use the company’s own press releases or its home-exchange announcements, since there is no SEC 8-K feed for a non-filer. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Search for the latest news about bili (bilibili) u.s. stocks

For “Search for the latest news about bili (bilibili) u.s. stocks”, the matching SEC registrant is Bilibili Inc., which trades as BILI, BLBLF and files under Central Index Key 1723690. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-08, across 350 filings on record. This is reference material, not trading advice.

In September 2014, Hode HK established a wholly owned PRC subsidiary, Hode Shanghai Limited, which we refer to as Hode Shanghai in this annual report. Due to restrictions imposed by PRC laws and regulations on foreign ownership of companies that engage in internet and other related business, Hode Shanghai later entered into a series of contractual arrangements with Hode Information Technology and Shanghai Kuanyu, and their respective shareholders, and our subsidiary, Chaodian (Shanghai) Technology Co., Ltd., which we refer to as Chaodian Technology in this annual report, entered into a series of contractual arrangements with Chaodian Culture and its individual shareholders. We have also entered into contractual arrangements with several other affiliated entities and their respective nominee shareholders, through some of our subsidiaries other than Hode Shanghai or Chaodian Technology.

For the latest news, the fastest official source is the filing feed: Bilibili Inc. (CIK 1723690) filed 221 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-08, and its overall latest filing is a 6-K dated 2026-10-08. Companies must file an 8-K within four business days of most material events.

Updated Oct 25, 2026 ET

Sellas life science reddit

For “Sellas life science reddit”, the matching SEC registrant is SELLAS Life Sciences Group, Inc., which trades as SLS and files under Central Index Key 1390478. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was GALENA BIOPHARMA, INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-11, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-19 by SELLAS Life Sciences Group, Inc. (CIK 1390478) — source document:

We are a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. Our product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and SLS009 (tambiciclib), a highly selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. Galinpepimut-S: Highly Novel and Engineered Immunotherapy Targeting the WT1 Antigen Our lead product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the WT1 protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers, and solid tumor indications.

Financial trend for SELLAS Life Sciences Group, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.00 million (2022-12-31) to $0 (2023-12-31), a change of -100.0%; net income (loss) went from -$41.30 million (2022-12-31) to -$26.86 million (2025-12-31), a change of +35.0%; total assets went from $20.94 million (2022-12-31) to $78.34 million (2025-12-31), a change of +274.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1390478, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures SELLAS Life Sciences Group, Inc. did not tag for that period.

Reddit threads about SELLAS Life Sciences Group, Inc., CIK 1390478, are user opinions, not disclosures. Claims made there can be checked against the filer record: 1001 filings sit in its recent EDGAR index, the newest a 8-K dated 2026-08-11, and 251 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 265 8-K or 6-K reports in SELLAS Life Sciences Group, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-18 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1390478 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2011-04-21. Insider trades for SELLAS Life Sciences Group, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Septerna

For “Septerna”, the matching SEC registrant is Septerna, Inc., which trades as SEPN and files under Central Index Key 1984086. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-19 (this view begins at filings dated on or before 2026-08-14), across 169 filings on record. This is reference material, not trading advice.

Financial trend for Septerna, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $21.50 million (2025-09-30) to $26.75 million (2026-06-30), a change of +24.4%; net income (loss) went from $8.17 million (2025-09-30) to -$13.03 million (2026-06-30), a change of -259.5%; total assets went from $606.65 million (2025-09-30) to $566.74 million (2026-06-30), a change of -6.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1984086, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Septerna, Inc. did not tag for that period.

Septerna, Inc. has 169 filings in its recent EDGAR index, including 2 annual reports and 6 quarterly reports; its newest filing is a 4 from 2026-10-19.

Current reports. Of the 26 8-K or 6-K reports in Septerna, Inc.’s recent EDGAR index, the 4 listed here run from 2026-01-12 to 2026-04-13, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 169 recent EDGAR filings, Septerna, Inc. most often filed 4 (61), 8-K (26), 3 (19), 144 (15). A selection from 2026-08-14 to 2026-09-03:

The full record for CIK 1984086 is on the EDGAR company page; the latest 10-K there is dated 2026-03-09 and the oldest filing in the recent index dates from 2023-07-13. One example from this record is the 3 filed 2026-09-03 (document). Insider trades for Septerna, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Siddhi risk analysis and services mobile apps

Because this search is about mobile apps from Siddhi risk analysis and services, the record that answers it is the developer listing in the app stores. Check Google Play (Developer field) and the App Store (Seller field): a match to the company’s legal name, plus a privacy policy hosted on its own domain, is what confirms an app is genuinely the company’s.

No SEC filer could be matched to “Siddhi risk analysis and services mobile apps” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Siddhi risk analysis and services”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “siddhi” (search terms considered: siddhi, risk, analysis, services).

Even the shorter phrase “Siddhi risk analysis” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (siddhi, risk, analysis, services) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 13 entities whose registered name contains the word “siddhi”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “siddhi” 13, “risk” 444, “analysis” 51, “services” 472. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “siddhi”: MGF PARTNERS, L.P. - SIDDHI CAPITAL II SERIES (CIK 2003815), SIDDHI ACQUISITION CORP (CAYMAN ISLANDS) (CIK 2034037), SIDDHI ACQUISITION CORP. (CIK 1831762); containing “risk”: 0XPARTNERS RISK-ON, LP (CIK 1934163), 364 RISK CAPITAL LLC (CIK 2079844), 5:15 TAIL RISK PARTNERS LP (CIK 1546183); containing “analysis”: ALLSOURCE ANALYSIS, INC. (CIK 1615073), ALVAREZ & MARSAL DISPUTE ANALYSIS & FORENSIC SERVICES LLC (CIK 1396816), ANALYSIS & TECHNOLOGY INC (CIK 310876); containing “services”: 1 4 SURGICAL SERVICES LLC (CIK 1229382), 1 NORTH WEALTH SERVICES LLC (CIK 1641761), 1 SOURCE LAB & MEDICAL SERVICES, LLC (CIK 1754517). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Updated Oct 25, 2026 ET

Spectral ai mdai october 2026 news

For “Spectral ai mdai october 2026 news”, the matching SEC registrant is Spectral AI, Inc., which trades as MDAI, MDAIW and files under Central Index Key 1833498. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was Rosecliff Acquisition Corp I. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-29 (this view begins at filings dated on or before 2026-06-29), across 299 filings on record. This is reference material, not trading advice.

More of the filing record for Spectral AI, Inc. (CIK 1833498), filings 2026-05-08 to 2026-05-20: 4 on 2026-05-20; 4 on 2026-05-18; 4 on 2026-05-18; 10-Q on 2026-05-13; SCHEDULE 13G/A on 2026-05-08. Each form type has a fixed purpose under SEC rules, so the mix shows what kind of events the company has been reporting.

Updated Oct 25, 2026 ET

Stln

For “Stln”, the matching SEC registrant is Starling Oncology, Inc., which trades as STLN, DFPH, STLNW and files under Central Index Key 1799191. EDGAR puts it in the “Services-Offices & Clinics of Doctors of Medicine” industry code with DE as its state or country of incorporation; its earlier registered name was Oncology Institute, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-02, across 543 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-12 by Starling Oncology, Inc. (CIK 1799191) — source document:

Formed in 2007, the business of what is now The Oncology Institute, Inc. ("TOI", the "Company", "we", or "our) and its affiliated professional corporations was created initially as a collection of community oncology practices in southern California, and has evolved to be a national leader in the pursuit of reducing the ever-rising cost of oncology care, while embracing clinical best practices, state-of-the-art technology, and compassionate treatment of patients. While we continue our original purpose of seeing our patients on a fee-for-service basis for their oncology, hematology, specialty infusion, oral pharmacy needs, as well as enrolling patients in clinical trials, where appropriate, TOI's true mission lies in our differentiated ability to partner with managed care providers and other risk-bearing entities to transfer the risk and patient coordination responsibility of treating cancer in the subset of the population that is experiencing an oncology treatment episode.

Financial trend for Starling Oncology, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $252.48 million (2022-12-31) to $502.73 million (2025-12-31), a change of +99.1%; net income (loss) went from $152,000 (2022-12-31) to -$60.61 million (2025-12-31), a change of -39972.4%; total assets went from $261.67 million (2022-12-31) to $164.66 million (2025-12-31), a change of -37.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1799191, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Starling Oncology, Inc. did not tag for that period.

Starling Oncology, Inc. has 543 filings in its recent EDGAR index, including 6 annual reports and 20 quarterly reports; its newest filing is a 8-K from 2026-09-02.

Current reports. Of the 79 8-K or 6-K reports in Starling Oncology, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-03 to 2026-09-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1799191 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2020-01-14. Insider trades for Starling Oncology, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Stride ncr atleos dillard's prog holdings news

The shorter “news” wording of the Stride, NCR Atleos, Dillard’s and PROG Holdings query. What follows is each company’s own disclosure trail as EDGAR showed it on Oct 25, 2026.

PROG Holdings, Inc. (PRG) — recent current reports: the 8-K of 2026-03-10 covering 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits); the 8-K of 2026-03-02 covering 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2023-12-31: revenue of $2.34 billion, net income (loss) $138.84 million (10-K, 2026-02-18).

NCR Atleos Corp (NATL) — recent current reports: the 8-K of 2026-05-06 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-03-12 covering 1.01 (entry into a material definitive agreement), 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits). Year to 2023-12-31: revenue of $4.19 billion, net income (loss) -$150.00 million (10-K, 2026-02-27).

DILLARD'S, INC. (DDS) — EDGAR lists the 8-K of 2026-05-14 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-03-20 covering 1.01 (entry into a material definitive agreement), 3.02 (unregistered sales of equity securities), 9.01 (financial statements and exhibits). Year to 2024-02-03: annual sales of $6.87 billion, net result $738.85 million (10-K, 2026-03-27).

Stride, Inc. (LRN): its index shows the 8-K of 2026-04-28 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-01-27 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits). Year to 2016-06-30: reported revenue $872.70 million, bottom line $9.04 million (10-K, 2018-08-08).

Item 1.01 — entry into a material definitive agreement — the item a significant partnership or contract would be filed under — appears this many times per company: PRG 6 (latest 2026-01-02), NATL 5 (latest 2026-03-12), DDS 3 (latest 2026-03-20), LRN 6 (latest 2026-10-09).

Updated Oct 25, 2026 ET

Suburban propane partners sph news october 2026

For “Suburban propane partners sph news october 2026”, the matching SEC registrant is SUBURBAN PROPANE PARTNERS LP, which trades as SPH and files under Central Index Key 1005210. EDGAR puts it in the “Retail-Miscellaneous Retail” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 1000 filings on record. This is reference material, not trading advice.

More of the filing record for SUBURBAN PROPANE PARTNERS LP (CIK 1005210), filings 2026-05-07 to 2026-09-01: 4 on 2026-09-01; 144 on 2026-08-27; 10-Q on 2026-08-06; SCHEDULE 13G/A on 2026-05-11; 10-Q on 2026-05-07. Each form type has a fixed purpose under SEC rules, so the mix shows what kind of events the company has been reporting.

Updated Oct 25, 2026 ET

Summit funding, inc. dba blue adobe mortgage

What this search refers to. Summit Funding, Inc. (doing business as Blue Adobe Mortgage) is a mortgage lender; its licences are listed on NMLS Consumer Access, the official record for mortgage companies. Official source: www.nmlsconsumeraccess.org.

No SEC filer could be matched to “Summit funding, inc. dba blue adobe mortgage” with a single, clear Central Index Key: the phrase “Summit funding, inc. dba blue adobe” appears in 425+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “summit” (search terms considered: summit, funding, dba, blue, adobe, mortgage).

A broader EDGAR full-text search for the shorter phrase “Summit funding inc.” finds 4700+ filing documents; among the top 100, the filers mentioning it most are FEDERAL HOME LOAN MORTGAGE CORP (FMCC, FMCCG, FMCCI, FMCCJ, FMCCL, FMCCN, FMCCO, FMCCS, FMCCT, FMCKI, FMCKL, FMCKN, FREJN, FREJO) (CIK 0001026214) (87); NORTHERN LIGHTS FUND TRUST II (CIK 0001518042) (7); FEDERAL HOME LOAN MORTGAGE CORP (FMCC, FMCCG, FMCCJ, FMCCL, FMCCN, FMCCO, FMCCS, FMCKJ, FMCKL, FMCKM, FMCKN, FMCKO, FREJN, FREJO) (CIK 0001026214) (4). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Summit funding, inc. dba blue adobe”, filings range from 2013-08-05 to 2025-11-07. The filers whose documents mention it most often are FEDERAL HOME LOAN MORTGAGE CORP (FMCC, FMCCG, FMCCI, FMCCJ, FMCCL, FMCCN, FMCCO, FMCCS, FMCCT, FMCKI, FMCKL, FMCKN, FREJN, FREJO) (CIK 0001026214) (100 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 186+ entities whose registered name contains the word “summit”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “summit” 472, “funding” 494, “dba” 106, “blue” 483, “adobe” 8, “mortgage” 491. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: if “summit” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Supx

For “Supx”, the matching SEC registrant is SuperX AI Technology Ltd, which trades as SUPX and files under Central Index Key 1897087. EDGAR puts it in the “Services-Management Consulting Services” industry code with Virgin Islands, British as its state or country of incorporation; its earlier registered name was Super X AI Technology Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-10-14 (this view begins at filings dated on or before 2026-08-19), across 177 filings on record. This is reference material, not trading advice.

SuperX AI Technology Ltd has 177 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a SCHEDULE 13G/A from 2026-10-14.

Current reports. Of the 83 8-K or 6-K reports in SuperX AI Technology Ltd’s recent EDGAR index, the 4 listed here run from 2026-08-07 to 2026-08-28, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 177 recent EDGAR filings, SuperX AI Technology Ltd most often filed 6-K (83), UPLOAD (13), F-1/A (13), 3 (12). A selection from 2026-04-17 to 2026-07-22:

The full record for CIK 1897087 is on the EDGAR company page; the latest 20-F there is dated 2025-10-31 and the oldest filing in the recent index dates from 2021-12-15. One example from this record is the 6-K filed 2026-09-03 (document). Insider trades for SuperX AI Technology Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tcpc blackrock tcp capital latest news october 2026

For “Tcpc blackrock tcp capital latest news october 2026”, the matching SEC registrant is BlackRock TCP Capital Corp., which trades as TCPC and files under Central Index Key 1370755. EDGAR puts it in the “no SIC description” industry code with DE as its state or country of incorporation; its earlier registered name was TCP Capital Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 40-17G filed 2026-10-15, across 840 filings on record. This is reference material, not trading advice.

The Company is a Delaware corporation formed on April 2, 2012 and is an externally managed, closed-end, non-diversified management investment company. We have elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. We seek to achieve our investment objective primarily through investments in debt securities of middle-market companies, which we typically define as those with enterprise values between $100 million and $1.5 billion. While we intend to primarily focus on privately negotiated investments in debt of middle-market companies, we may make investments of all kinds and at all levels of the capital structure, including in equity interests such as preferred or common stock and warrants or options received in connection with our debt investments.

Updated Oct 25, 2026 ET

Teledyne reynolds uk

For “Teledyne reynolds uk”, the matching SEC registrant is TELEDYNE TECHNOLOGIES INC, which trades as TDY and files under Central Index Key 1094285. EDGAR puts it in the “Search, Detection, Navigation, Guidance, Aeronautical Sys” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-10-23, across 1014 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-20 by TELEDYNE TECHNOLOGIES INC (CIK 1094285) — source document:

Who We Are Teledyne Technologies Incorporated is a Delaware corporation that provides enabling technologies to sense, analyze and distribute information for industrial growth markets that require advanced technology and high reliability. These markets include aerospace and defense, factory automation, air and water quality environmental monitoring, electronics design and development, oceanographic research, deepwater oil and gas exploration and production, medical imaging and pharmaceutical research. Our products include digital imaging sensors, cameras and systems within the visible, infrared and X-ray spectra, monitoring and control instrumentation for marine and environmental applications, harsh environment interconnects, electronic test and measurement equipment, aircraft information management systems, and defense electronics and satellite communication subsystems. We also supply engineered systems for defense, space, environmental and energy applications.

Financial trend for TELEDYNE TECHNOLOGIES INC from annual reports, periods 2023-01-01 to 2025-12-28: net income (loss) went from $788.60 million (2023-01-01) to $894.80 million (2025-12-28), a change of +13.5%; total assets went from $14.35 billion (2023-01-01) to $15.29 billion (2025-12-28), a change of +6.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1094285, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TELEDYNE TECHNOLOGIES INC did not tag for that period.

TELEDYNE TECHNOLOGIES INC has 1014 filings in its recent EDGAR index, including 12 annual reports and 39 quarterly reports; its newest filing is a 10-Q from 2026-10-23.

Current reports. Of the 142 8-K or 6-K reports in TELEDYNE TECHNOLOGIES INC’s recent EDGAR index, the 4 listed here run from 2026-07-22 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1094285 is on the EDGAR company page; the latest 10-K there is dated 2026-02-20 and the oldest filing in the recent index dates from 2014-04-24. Insider trades for TELEDYNE TECHNOLOGIES INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tenable india

For “Tenable india”, the matching SEC registrant is Tenable Holdings, Inc., which trades as TENB and files under Central Index Key 1660280. EDGAR puts it in the “Services-Prepackaged Software” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-13 (this view begins at filings dated on or before 2026-08-25), across 872 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by Tenable Holdings, Inc. (CIK 1660280) (passage 2, continuing from the earlier excerpt) — source document:

For most organizations, the attack surface has expanded to include: • Complex and dynamic hybrid and multi-cloud environments, which organizations are rapidly adopting even as they face a shortage of cloud security expertise; • AI platforms, including agentic AI, the use of which is introducing risk by creating often-invisible security gaps and blind spots; • Human, machine and AI identities, the dramatic rise of which is creating a sense of urgency to improve governance and access controls, and the removal of excessive privileges that can open up attack pathways within an organization; • An assortment of operational technology, or OT, such as industrial control systems, or ICS, and supervisory control and data acquisition, or SCADA systems, which are increasingly at risk due to AI growth velocity — emerging use cases for OT include AI data centers that are being built all around the world; • Personal devices, including mobile phones and tablets, internet of things, or IoT, devices and other types of “shadow IT” and "shadow AI" used by employees, often without the knowledge of the IT and security teams; and • Virtual machines, microservices, open-source code repositories, containers and

Financial trend for Tenable Holdings, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $252.44 million (2025-09-30) to $268.51 million (2026-06-30), a change of +6.4%; net income (loss) went from $2.26 million (2025-09-30) to $3.81 million (2026-06-30), a change of +68.4%; total assets went from $1.65 billion (2025-09-30) to $1.57 billion (2026-06-30), a change of -4.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1660280, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Tenable Holdings, Inc. did not tag for that period.

Tenable Holdings, Inc. has 872 filings in its recent EDGAR index, including 8 annual reports and 25 quarterly reports; its newest filing is a 8-K from 2026-10-13.

Current reports. Of the 75 8-K or 6-K reports in Tenable Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-04 to 2026-05-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1660280 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2016-06-29. One example from this record is the 8-K filed 2026-09-15 (document). Insider trades for Tenable Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tim palmer quantum mechanics

What this search refers to. Tim Palmer is a University of Oxford physicist known for work on climate prediction and quantum-mechanics foundations; this is an academic topic, not an issuer. Official source: arxiv.org.

No SEC filer could be matched to “Tim palmer quantum mechanics” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Tim palmer quantum mechanics”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “tim” (search terms considered: tim, palmer, quantum, mechanics).

Even the shorter phrase “Tim palmer quantum” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (tim, palmer, quantum, mechanics) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 198+ entities whose registered name contains the word “tim”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “tim” 250, “palmer” 264, “quantum” 343, “mechanics” 12. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “tim”: AB-0519 FUND I, A SERIES OF TIM CHEN ANGEL DEALS, LP (CIK 1983365), ADAMS TIM M (CIK 1457431), ADUDDELL TIM (CIK 1119045); containing “palmer”: 125 PALMER APARTMENTS (CIK 1696991), 1304 PALMER DRIVE INVESTOR, LLC (CIK 2086762), ARNOLD PALMER GOLF CO (CIK 80397); containing “quantum”: 18W QUANTUM OPPORTUNITY FUND I, L.P. (CIK 2014331), 18W QUANTUM OPPORTUNITY FUND II, L.P. (CIK 2045986), ALPHA EDISON QUANTUM II, L.L.C. (CIK 2140399); containing “mechanics”: ADVANCED BIO-MECHANICS INC (CIK 1367459), APPLIED ELECTRO MECHANICS INC (CIK 1216222), FARMERS & MECHANICS BANK (CIK 230208). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “tim” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Trimas corporation trs latest news october 2026

For “Trimas corporation trs latest news october 2026”, the matching SEC registrant is TRIMAS CORP, which trades as TRS and files under Central Index Key 842633. EDGAR puts it in the “Metal Forgings & Stampings” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-14, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-02 by TRIMAS CORP (CIK 842633) — source document:

TriMas designs, develops and manufactures a diverse portfolio of products primarily for the consumer products, aerospace and defense, and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. We believe our businesses share important attributes, including: innovative produc t technologies and features; customer-approved processes and qualified products; demonstrated operating discipline; strong cash generation; long-term growth opportunities; and a commitment to sustainability. Headquartered in Bloomfield Hills, Michigan, TriMas, including our Aerospace operations, has approximately 3,700 employees who serve our customers from 37 manufacturing and support locations in 13 countries. On November 4, 2025, we entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Takeoff Buyer, Inc. (the “Purchaser”), an affiliate of Tinicum L.P. and funds managed by Blackstone, Inc., to sell TriMas Aerospace.

Financial trend for TRIMAS CORP from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $883.83 million (2022-12-31) to $645.72 million (2025-12-31), a change of -26.9%; net income (loss) went from $66.17 million (2022-12-31) to $120.14 million (2025-12-31), a change of +81.6%; total assets went from $1.30 billion (2022-12-31) to $1.49 billion (2025-12-31), a change of +13.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 842633, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TRIMAS CORP did not tag for that period.

For the latest news, the fastest official source is the filing feed: TRIMAS CORP (CIK 842633) filed 146 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-07-30, and its overall latest filing is a 4 dated 2026-10-14. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 146 8-K or 6-K reports in TRIMAS CORP’s recent EDGAR index, the 4 listed here run from 2026-03-18 to 2026-07-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 842633 is on the EDGAR company page; the latest 10-K there is dated 2026-03-02 and the oldest filing in the recent index dates from 2012-04-04. Insider trades for TRIMAS CORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Trinet tnet latest news october 2026

For “Trinet tnet latest news october 2026”, the matching SEC registrant is TRINET GROUP, INC., which trades as TNET and files under Central Index Key 937098. EDGAR puts it in the “Services-Business Services, NEC” industry code with DE as its state or country of incorporation; its earlier registered name was TRINET GROUP INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-14, across 1002 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-12 by TRINET GROUP, INC. (CIK 937098) — source document:

TriNet is a leading provider of HR solutions for SMBs. We offer technology-enabled services that include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. Our long-term objective is to be the premier provider of HR services for a broad range of SMBs through industry-leading benefits, sales distribution excellence, and a world-class services delivery model. Since our founding in 1988, TriNet has served, and continues to serve, thousands of SMBs. We are the largest publicly traded company in the U.S. that focuses primarily on the PEO business, in terms of market capitalization as of December 31, 2025.

Financial trend for TRINET GROUP, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $4.91 billion (2022-12-31) to $5.01 billion (2025-12-31), a change of +2.1%; net income (loss) went from $355.00 million (2022-12-31) to $155.00 million (2025-12-31), a change of -56.3%; total assets went from $3.44 billion (2022-12-31) to $3.80 billion (2025-12-31), a change of +10.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 937098, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TRINET GROUP, INC. did not tag for that period.

For the latest news, the fastest official source is the filing feed: TRINET GROUP, INC. (CIK 937098) filed 82 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-14, and its overall latest filing is a 8-K dated 2026-09-14. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 82 8-K or 6-K reports in TRINET GROUP, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-27 to 2026-09-14, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 937098 is on the EDGAR company page; the latest 10-K there is dated 2026-02-12 and the oldest filing in the recent index dates from 2019-02-14. Insider trades for TRINET GROUP, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ucfi

For “Ucfi”, the matching SEC registrant is CN Healthy Food Tech Group Corp., which trades as UCFI, UCFIW and files under Central Index Key 1901203. EDGAR puts it in the “Food and Kindred Products” industry code with DE as its state or country of incorporation; its earlier registered name was Iron Horse Acquisitions Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-13, across 117 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by CN Healthy Food Tech Group Corp. (CIK 1901203) — source document:

Our Holding Company Structure and China Business Operations The figure below illustrates our corporate structure, including our major subsidiaries and other subsidiaries as of the reporting date of this annual report. CN Healthy Tech Group Corp.is a holding company without substantive operations, with the Group’s core business being managed by its domestic wholly-owned subsidiaries (together, the “Group”). These entities focus on developing, manufacturing, and marketing premium health foods driven by AI-powered biotechnology and biotech innovation. By integrating modern biotechnology with traditional Chinese medicine principles, the Group addresses the market’s growing demand for safe, high-quality nutritional products. The group’s wholly-owned subsidiaries within China are as follows: ● Heilongjiang Zhongnengliangke Agricultural Technology Co., Ltd. (a wholly-owned subsidiary of Grain Science Innovation Biotechnology (BVI) Limited (“CFI HK”)), a limited liability company established under the laws of the People’s Republic of China, hereinafter referred to as “Operating Company 1”) ● Harbin Kangliang Kechuang Co., Ltd. (a wholly-owned subsidiary of Operating Company 1, a limited liability company established in accordance with the laws of the People’s Republic of China, hereinafter referred to as “Operating Company 2”) ● Heilongjiang Beikang Biotechnology Co., Ltd.

Financial trend for CN Healthy Food Tech Group Corp. from annual reports, periods 2022-12-31 to 2024-12-31: net income (loss) went from -$181,003 (2022-12-31) to $1.38 million (2024-12-31), a change of +860.1%; total assets went from $671,667 (2022-12-31) to $72.80 million (2024-12-31), a change of +10738.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1901203, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures CN Healthy Food Tech Group Corp. did not tag for that period.

CN Healthy Food Tech Group Corp. has 117 filings in its recent EDGAR index, including 3 annual reports and 8 quarterly reports; its newest filing is a 8-K from 2026-10-13.

Current reports. Of the 20 8-K or 6-K reports in CN Healthy Food Tech Group Corp.’s recent EDGAR index, the 4 listed here run from 2025-10-06 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1901203 is on the EDGAR company page; the latest 10-K/A there is dated 2026-06-12 and the oldest filing in the recent index dates from 2022-01-24. Insider trades for CN Healthy Food Tech Group Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Veeva aspen

What this search refers to. “Veeva Aspen” pairs Veeva Systems (NYSE: VEEV, an SEC filer) with “Aspen”, which may refer to Aspen Pharmacare or Aspen Technology; the combined query is not one registrant. Official source: www.sec.gov.

No SEC filer could be matched to “Veeva aspen” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Veeva aspen”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “veeva” (search terms considered: veeva, aspen).

EDGAR’s company index has 1 entities whose registered name contains the word “veeva”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “veeva” 1, “aspen” 254. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “veeva”: VEEVA SYSTEMS INC (CIK 1393052); containing “aspen”: 2021 ASPEN MOUNTAIN CHALET, LLC (CIK 1855825), AP VIII ASPEN HOLDINGS GP, LLC (CIK 1890116), AP VIII ASPEN HOLDINGS, L.P. (CIK 1890013). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “veeva” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Veritone careers ai machine learning engineer jobs

For “Veritone careers ai machine learning engineer jobs”, the matching SEC registrant is Veritone, Inc., which trades as VERI and files under Central Index Key 1615165. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-01, across 595 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-04-15 by Veritone, Inc. (CIK 1615165) — source document:

Veritone, Inc. (collectively with our subsidiaries, referred to as “Veritone,” “Company,” “we,” “our,” and “us”) is a provider of artificial intelligence (“AI”) computing solutions. We are driven by the belief that AI is key to building a safer, more efficient, transparent and empowered society. Our mission is to be an active contributor to making the world better through AI. As creators of one of the world’s first AI operating systems, we are augmenting the human workforce by transforming use-case concepts into tangible, industry-leading applications and solutions. Our proprietary AI operating system, aiWARE ™ , uses machine learning algorithms, or AI models, together with a suite of powerful applications, to reveal valuable insights from vast amounts of structured and unstructured data. aiWARE serves as the foundation for our AI solutions and bespoke applications and offers access to hundreds of cognitive categories through one common software infrastructure.

Financial trend for Veritone, Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $99.99 million (2023-12-31) to $92.64 million (2024-12-31), a change of -7.4%; net income (loss) went from -$58.62 million (2023-12-31) to -$111.73 million (2025-12-31), a change of -90.6%; total assets went from $378.86 million (2023-12-31) to $182.28 million (2025-12-31), a change of -51.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1615165, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Veritone, Inc. did not tag for that period.

For reported results, Veritone, Inc.’s (CIK 1615165) latest 10-Q is dated 2026-08-13 and its latest annual report (10-K) 2026-04-15. Earnings releases appear as 8-K Item 2.02 filings; 43 are in the recent index, the newest on 2026-08-13.

Current reports. Of the 127 8-K or 6-K reports in Veritone, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-16 to 2026-10-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1615165 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-29 and the oldest filing in the recent index dates from 2014-07-31. Insider trades for Veritone, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Vicore pharma

For “Vicore pharma”, the matching SEC registrant is Vicore Pharma Holding AB, which trades as VCRE and files under Central Index Key 2124403. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Sweden as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-22, across 11 filings on record. This is reference material, not trading advice.

Vicore Pharma Holding AB has 11 filings in its recent EDGAR index; its newest filing is a 6-K from 2026-10-22.

Current reports. Of the 4 8-K or 6-K reports in Vicore Pharma Holding AB’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 11 recent EDGAR filings, Vicore Pharma Holding AB most often filed 6-K (4), SCHEDULE 13G (1), S-8 (1), SEC STAFF ACTION (1). A selection from 2026-06-09 to 2026-10-13:

The full record for CIK 2124403 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-04-17. Insider trades for Vicore Pharma Holding AB appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET